In the latest study, Huang et al. found that FTO expression in high-grade serous ovarian cancer (HGSOC) tumor cells were significantly lower than that in other tissues, and it had a significant inhibitory effect on ovarian cancer cells (47). This evidence concerns the gene FTO and neoplasm.